Neuroendocrine Cancer Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2016 | 111,376 | 49,788 | 61,588 | 24.8 | — |
| 2017 | 127,891 | 87,013 | 40,878 | 19.8 | — |
| 2018 | 155,697 | 115,348 | 40,349 | 19.2 | — |
| 2019 | 177,739 | 127,827 | 49,912 | 22.0 | — |
| 2020 | 306,735 | 132,158 | 174,577 | 37.1 | 18% |
| 2021 | 257,208 | 124,538 | 132,670 | 52.2 | 44% |
| 2022 | 218,371 | 182,299 | 36,072 | 38.2 | 65% |
| 2023 | 286,106 | 260,412 | 25,694 | 28.0 | 57% |
In its most recent public year (2023), this organization brought in $25,694 more than it spent. Its reserves stood at about 28 months of spending, up from 24.8 in 2016. Staff pay was 57% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works